GB992956A - Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof - Google Patents

Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof

Info

Publication number
GB992956A
GB992956A GB20020/61A GB2002061A GB992956A GB 992956 A GB992956 A GB 992956A GB 20020/61 A GB20020/61 A GB 20020/61A GB 2002061 A GB2002061 A GB 2002061A GB 992956 A GB992956 A GB 992956A
Authority
GB
United Kingdom
Prior art keywords
carboxylic acid
esters
salts
pharmaceutical preparations
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB20020/61A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUSTAVE MARIE JOSEPH BOUCHER
Original Assignee
GUSTAVE MARIE JOSEPH BOUCHER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR829133A external-priority patent/FR51M/fr
Application filed by GUSTAVE MARIE JOSEPH BOUCHER filed Critical GUSTAVE MARIE JOSEPH BOUCHER
Publication of GB992956A publication Critical patent/GB992956A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Pharmaceutical compositions having psychoequilibrating properties comprise a carrier and 5-pyrrolidone-2-carboxylic acid or a salt or ester thereof, e.g. the Ca, Na, Fe or Mg salt or the monoglyceryl ester. They may be in conventional forms suitable for oral and parenteral administration.
GB20020/61A 1960-06-02 1961-06-02 Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof Expired GB992956A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR828994 1960-06-02
FR829133A FR51M (en) 1960-06-03 1960-06-03

Publications (1)

Publication Number Publication Date
GB992956A true GB992956A (en) 1965-05-26

Family

ID=26186251

Family Applications (1)

Application Number Title Priority Date Filing Date
GB20020/61A Expired GB992956A (en) 1960-06-02 1961-06-02 Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof

Country Status (2)

Country Link
BE (2) BE604312A (en)
GB (1) GB992956A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123948A1 (en) * 1983-04-04 1984-11-07 Teijin Limited External pharmaceutical composition
FR2704395A1 (en) * 1993-04-29 1994-11-04 Boiron Nutritional supplement which can be taken by mouth, intended for improving mental activity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123948A1 (en) * 1983-04-04 1984-11-07 Teijin Limited External pharmaceutical composition
FR2704395A1 (en) * 1993-04-29 1994-11-04 Boiron Nutritional supplement which can be taken by mouth, intended for improving mental activity

Also Published As

Publication number Publication date
BE604313A (en) 1961-09-18
BE604312A (en) 1961-09-18

Similar Documents

Publication Publication Date Title
MY6400061A (en) Pharmaceutical compositions comprising a-aryloxy-aliphatic carboxylic acids and/or a-arylimino-aliphatic carboxylic acids, their esters and salts
ES368496A1 (en) Aqueous doxycycline compositions
IL37280A (en) Adenosine-5'-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB1341794A (en) Medicament for the treatment of hepatic disorders
GB992956A (en) Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof
CA936533A (en) 5-aryl-2,3-dihydro-2,2(or 3,3) dimethyl-5h-imidazo(2,1-a) isoindol-5-ols and 2(4,4(5,5) dimethyl-2-imidazolin-2-yl) bensophenone acid addition salts and processes for their preparation
IL37013A0 (en) Basically substituted alkylidene-aminooxyalkyl carboxylic acid esters,their preparation and pharmaceutical compositions containing them
GB1202148A (en) Pharmaceutical compositions
GB1358098A (en) Anti-inflammatory preparations containing tetrahydrocarbazole derivatives
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
ES483087A1 (en) 5(6)-(2-Amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them.
GB1268188A (en) N-hydroxyalkyl-2,4,6-triiodosuccinanilic acids and their use as x-ray contrast agents
FR2081580A1 (en) Pharmacol-active 2,4,6-trimethoxybenzoates
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
GB1250279A (en)
GB933605A (en) Pharmaceutical preparations containing cyclopropane carboxylic acid and the salts thereof
ES370501A1 (en) Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
ZA716766B (en) 0,0-dialkyl-s-phenyl-dithiophosphoric acid esters,process for the preparation and their use as insecticides
AU252896B2 (en) Therapeutic composition containing 4-hydroxybutyric acid or salts thereof
AU421496B2 (en) Furan 2, 5 dicarboxylic acid diamides and their use as agents for combating harmful bacteria
AU445963B2 (en) 5-thiazole, carboxylic acid derivatives, process for the preparation thereof and pharmaceutical compositions containing same
AU456961A (en) Therapeutic composition containing 4-hydroxybutyric acid or salts thereof
CA783080A (en) Carboxylic acid amides, preparation thereof and anthelmintic pharmaceutical compositions
AU252959B2 (en) A delayed release medicament preparation in oral dosage form and process for making the same
AU3385368A (en) Furan 2, 5 dicarboxylic acid diamides and their use as agents for combating harmful bacteria